{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:12:04Z","timestamp":1791036724217,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":213,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003262.pub4","type":"reference-entry","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T22:35:18Z","timestamp":1299710118000},"source":"Crossref","is-referenced-by-count":32,"title":["Interventions for rosacea"],"prefix":"10.1002","author":[{"given":"Esther J","family":"van Zuuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbys","family":"Fedorowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"International Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB2|cit2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford","year":"1999","journal-title":"Archives of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub4-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0161-6420(96)30412-0","article-title":"The efficacy of topical metronidazole in the treatment of ocular rosacea","volume":"103","author":"Barnhorst","year":"1996","journal-title":"Ophthalmology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB4|cit4","first-page":"P10","article-title":"A multi-center, investigator-blind clinical trial to assess the safety and efficacy of metronidazole gel 1% as compared to metronidazole gel vehicle and metronidazole cream 1% in the treatment of rosacea","volume":"52","author":"Beutner","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB5|cit5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03259203","article-title":"A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea, a placebo controlled study","volume":"2","author":"Bitar","year":"1990","journal-title":"Drug Investigation"},{"key":"10.1002\/14651858.CD003262.pub4-BIB6|cit6","first-page":"187","article-title":"Metronidazole (Elyzol) 1% cream vs. placebo cream in the treatment of rosacea","volume":"26","author":"Bjerke","year":"1989","journal-title":"Clinical Trials Journal"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Dermato-Venerologica"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB8|cit8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1987.01660290077020","article-title":"Topical metronidazole therapy for rosacea","volume":"123","author":"Bleicher","year":"1987","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB9|cit9","first-page":"44","article-title":"A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea","volume":"61","author":"Breneman","year":"1998","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB10|cit10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"International Journal of Dermatology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB11|cit11","first-page":"11","article-title":"Photographic review of results from a clinical study comparing benzoyl peroxide 5%\/Clindamycin 1% topical gel with vehicle in the treatment of rosacea","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3109\/09546639309082150","article-title":"Topical azelaic acid in the treatment of rosacea","volume":"4","author":"Carmichael","year":"1993","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB14|cit14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","article-title":"Once-daily topical metronidazole cream formulations in the treatment of papules and pustules of rosacea","volume":"45","author":"Dahl","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB15|cit15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Rosso","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB16|cit16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Rosso","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB17|cit17","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea","volume":"7","author":"Rosso","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7 Pt 2","key":"10.1002\/14651858.CD003262.pub4-BIB18|cit18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1524-4725.2005.31735","article-title":"Efficacy of 1% 4-ethoxybenzaldehyde in reducing facial erythema","volume":"31","author":"Draelos","year":"2005","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB19|cit19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1473-2165.2006.00219.x","article-title":"An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients","volume":"5","author":"Draelos","year":"2006","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB20|cit20","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0926-9959(98)95615-X","article-title":"Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea","volume":"11","author":"Dreno","year":"1998","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB22|cit22","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"Journal of Drugs in Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD003262.pub4-BIB23|cit23","first-page":"687","article-title":"Rilmenidine in rosacea: a double blind study versus placebo","volume":"124","author":"Grosshans","year":"1997","journal-title":"Annales de Dermatologie et Venereologie"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB24|cit24","first-page":"S145","article-title":"Metronidazole 0.75% gel and lotion are both effective in the treatment of rosacea","volume":"12","author":"Guillet","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB25|cit25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","article-title":"The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double blind clinical trial","volume":"39","author":"Jorizzo","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB26|cit26","first-page":"702","article-title":"Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation","volume":"34","author":"Karsai","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB27|cit27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clinical and Experimental Dermatology"},{"issue":"32 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB28|cit28","first-page":"S143","article-title":"Dark sulfonated shale oil versus placebo in the systemic treatment of rosacea [P-011]","volume":"12","author":"Koch","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venerology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB29|cit29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea","volume":"205","author":"Ko\u00e7ak","year":"2002","journal-title":"Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB30|cit30","first-page":"183","article-title":"The comparative efficacy of sodium sulfacetamide 10%\/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (Metrogel) in the treatment of rosacea","volume":"3","author":"Lebwohl","year":"1995","journal-title":"Journal of Geriatric Dermatology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD003262.pub4-BIB31|cit31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7733","key":"10.1002\/14651858.CD003262.pub4-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","article-title":"Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial","volume":"2","author":"Marks","year":"1971","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB33|cit33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","article-title":"Topical metronidazole in the treatment of rosacea","volume":"2","author":"Monk","year":"1991","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB34|cit34","first-page":"185","article-title":"Topical treatment of acne rosacea with benzoyl peroxide acetone gel","volume":"32","author":"Montes","year":"1983","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2008.02940.x","article-title":"Comparative study of some treatment modalities of rosacea","volume":"23","author":"Mostafa","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB36|cit36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003262.pub4-BIB37|cit37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","article-title":"Treatment of rosacea with 1% metronidazole cream. A double-blind study","volume":"108","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB38|cit38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","article-title":"A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea","volume":"109","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"7971","key":"10.1002\/14651858.CD003262.pub4-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","article-title":"Treatment of rosacea by metronidazole","volume":"1","author":"Pye","year":"1976","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB40|cit40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-3083.2005.01248.x","article-title":"Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea","volume":"19","author":"Rigopoulos","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB41|cit41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","article-title":"A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea","volume":"102","author":"Saihan","year":"1980","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB42|cit42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB43|cit43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09546639709160276","article-title":"The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study","volume":"8","author":"Sauder","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB44|cit44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF03259568","article-title":"Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea","volume":"3","author":"Schachter","year":"1991","journal-title":"Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB45|cit45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Advances in Therapy"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub4-BIB46|cit46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-4632.2006.02944.x","article-title":"Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study","volume":"45","author":"Sharquie","year":"2006","journal-title":"International Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub4-BIB47|cit47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","article-title":"A clinical trial of tetracycline in rosacea","volume":"78","author":"Sneddon","year":"1966","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB48|cit48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10227-001-0144-4","article-title":"Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea","volume":"6","author":"Tan","year":"2002","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB49|cit49","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from 2 vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB50|cit50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from 2 vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB51|cit51","first-page":"541","article-title":"Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea","volume":"7","author":"Thiboutot","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub4-BIB52|cit52","first-page":"639","article-title":"A Multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance therapy","volume":"8","author":"Thiboutot","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB53|cit53","first-page":"357","article-title":"Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD003262.pub4-BIB54|cit54","first-page":"209","article-title":"Topical metronidazole in the treatment of rosacea","volume":"38","author":"Veien","year":"1986","journal-title":"Cutis"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB55|cit55","first-page":"472","article-title":"Comparative study of topical erythromycin and topical metronidazole in the treatment of rosacea","volume":"9","author":"Verea Hernando","year":"1992","journal-title":"Farmacia e Clinica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB56|cit56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD003262.pub4-BIB57|cit57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB58|cit58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"International Journal of Dermatology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB59|cit59","first-page":"3","article-title":"Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea","volume":"77","author":"Wolf","year":"2006","journal-title":"Cutis"},{"issue":"23","key":"10.1002\/14651858.CD003262.pub4-BIB60|cit60","first-page":"1490","article-title":"Acne rosacea: Efficacy of a metronidazole cream","volume":"12","author":"Aitken","year":"1983","journal-title":"La Presse M\u00e9dicale"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB61|cit61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1346-8138.1992.tb03227.x","article-title":"Oral spironolactone therapy in male patients with rosacea","volume":"19","author":"Aizawa","year":"1992","journal-title":"The Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB62|cit62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","article-title":"Adalapene vs. metronidazole gel for the treatment of rosacea","volume":"44","author":"Altinyazar","year":"2005","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB63|cit63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/106002808702100410","article-title":"Evaluation of topical metronidazole gel in acne rosacea","volume":"21","author":"Aronson","year":"1987","journal-title":"Drug Intelligence & Clinical Pharmacy"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub4-BIB64|cit64","first-page":"AB24","article-title":"Acne rosacea: an open comparative trial of azithromycin versus oxytetracycline therapy: study of 50 patients [P139]","volume":"54","author":"Bakar","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"19 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB65|cit65","first-page":"65","article-title":"Treatment of rosacea with photopnematic therapy [212]","volume":"39","author":"Bang Soon","year":"2007","journal-title":"Lasers in Surgery and Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB66|cit66","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bjo.66.6.386","article-title":"Oxytetracycline in the treatment of ocular rosacea: a double-blind trial","volume":"66","author":"Bartholomew","year":"1982","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB67|cit67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1473-2165.2008.00355.x","article-title":"Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation","volume":"7","author":"Berardesca","year":"2008","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB68|cit68","first-page":"55","article-title":"Perolen cream for therapy of rosacea","volume":"120","author":"Beridze","year":"2005","journal-title":"Georgian Medical News"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB69|cit69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.1982.tb00290.x","article-title":"Alcohol-induced rosacea flushing blocked by naloxone","volume":"107","author":"Bernstein","year":"1982","journal-title":"British Journal of Dermatology"},{"issue":"23","key":"10.1002\/14651858.CD003262.pub4-BIB70|cit70","first-page":"2295","article-title":"Rosacea. Clinical features and treatment","volume":"109","author":"Bjerke","year":"1989","journal-title":"Tidsskrift for den Norske laegeforening"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB71|cit71","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/0001555564358359","article-title":"Topical treatment with sulfur 10 percent for rosacea","volume":"64","author":"Blom","year":"1984","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB72|cit72","first-page":"185","article-title":"Treatment of Helicobacter pylori infection in the management of rosacea","volume":"6","author":"Bukvic-Mokos","year":"1998","journal-title":"Acta Dermatovenerologica Croatica"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB73|cit73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","article-title":"The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea","volume":"152","author":"Chu","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB74|cit74","first-page":"317","article-title":"Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%","volume":"79","author":"Col\u00f3n","year":"2007","journal-title":"Cutis"},{"issue":"6053","key":"10.1002\/14651858.CD003262.pub4-BIB75|cit75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmj.1.6053.105","article-title":"Clonidine and facial flushing in rosacea","volume":"1","author":"Cunliffe","year":"1977","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003262.pub4-BIB76|cit76","first-page":"176","article-title":"Double blind, parallel study of efficacy and safety of clindamycin lotion in the treatment of rosacea","volume":"41","author":"Witt","year":"1987","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB77|cit77","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2003.11.022","article-title":"The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: Evaluation of a single-site comparative trial subset","volume":"50","author":"Rosso","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub4-BIB78|cit78","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1346-8138.2005.tb00874.x","article-title":"Azithromycin in the treatment of papulopustular rosacea","volume":"32","author":"Dereli","year":"2005","journal-title":"The Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB79|cit79","first-page":"135","article-title":"Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea","volume":"76","author":"Draelos","year":"2005","journal-title":"Cutis"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub4-BIB80|cit80","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","article-title":"Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea","volume":"134","author":"Erdogan","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB81|cit81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB82|cit82","first-page":"129","article-title":"Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea","volume":"120","author":"Espagne","year":"1993","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB83|cit83","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.140.4.489","article-title":"Oral use of azithromycin for the treatment of acne rosacea","volume":"140","author":"Fernandez-Obregon","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB84|cit84","first-page":"585","article-title":"The face and mind evaluation study: An examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life","volume":"4","author":"Fleischer","year":"2005","journal-title":"Journal of Drugs in Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB85|cit85","first-page":"506","article-title":"Dimensions of the sample and power of clinical experimentation in a study of antibiotic therapy","volume":"108","author":"Frigerio","year":"1969","journal-title":"Bollettino Chimico Farmaceutico"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB86|cit86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB87|cit87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1468-3083.2008.02822.x","article-title":"Clinical efficacy of tacrolimus in rosacea","volume":"23","author":"Garg","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB88|cit88","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-3083.2005.01144.x","article-title":"Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?","volume":"19","author":"Gedik","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB89|cit89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000257895","article-title":"Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to rebound phenomenon","volume":"152","author":"Go","year":"1976","journal-title":"Dermatologica"},{"issue":"14","key":"10.1002\/14651858.CD003262.pub4-BIB90|cit90","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.1989.03420140014003","article-title":"New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects","volume":"261","author":"Goldsmith","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB91|cit91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2004.01472.x","article-title":"Continuous 'microdose' isotretinoin in adult recalcitrant rosacea","volume":"29","author":"Hofer","year":"2004","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB92|cit92","series-title":"Acne and related disorders - Proceedings of an international symposium","first-page":"301","article-title":"Isotretinoin in the treatment of rosacea and rhinophyma","author":"Irvine","year":"1988"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD003262.pub4-BIB93|cit93","first-page":"AB19","article-title":"Combined effect of anti-inflammatory dose doxycycline and azelaic acid gel 15% in the treatment of rosacea","volume":"56","author":"Jackson","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB94|cit94","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB95|cit95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/AO:37:2:077","article-title":"Effects of topical metranidazole in ocular rosacea","volume":"37","author":"Ko\u00e7ak-Altintas","year":"2005","journal-title":"Annals of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003262.pub4-BIB96|cit96","first-page":"729","article-title":"Treatment of rosacea. Clonidine (0.075 mg per day) versus placebo (initial results)","volume":"124","author":"Landuyt","year":"1997","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB97|cit97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546630601121078","article-title":"Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea","volume":"18","author":"Laquieze","year":"2007","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: An 8-week split-face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: A systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"68","key":"10.1002\/14651858.CD003262.pub4-BIB100|cit100","first-page":"61","article-title":"Ivermectin cream in rosacea: Comparison with metronidazole gel","volume":"151","author":"Loo","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"S20","key":"10.1002\/14651858.CD003262.pub4-BIB101|cit101","first-page":"25","article-title":"Randomized study of intense pulsed light and pulsed dye laser in the treatment of facial telangiectasia","volume":"40","author":"Meekin","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD003262.pub4-BIB102|cit102","first-page":"AB14","article-title":"The combination of metronidazole gel and sodium sulfacetamide cleanser is efficacious and well-tolerated by rosacea patients [P114]","volume":"58","author":"Mraz","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB103|cit103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/ICO.0b013e31815c18d6","article-title":"Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis","volume":"27","author":"M\u00e4\u00e4tt\u00e4","year":"2008","journal-title":"Cornea"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB104|cit104","first-page":"148","article-title":"Treatment of rosacea with tetracycline and metronidazole - A comparative study","volume":"35","author":"Nasir","year":"1985","journal-title":"The Journal of the Pakistan Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB105|cit105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","article-title":"The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream","volume":"109","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB106|cit106","first-page":"459","article-title":"Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea","volume":"8","author":"Ortiz","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub4-BIB107|cit107","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cgh.2008.02.054","article-title":"Small intestinal bacterial overgrowth in rosacea: Clinical effectiveness of its eradication","volume":"6","author":"Parodi","year":"2008","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB108|cit108","first-page":"AB64","article-title":"A double-blind, placebo-controlled study of a natural anti-inflammatory for treatment of rosacea","volume":"54","author":"Rehmus","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl1","key":"10.1002\/14651858.CD003262.pub4-BIB109|cit109","first-page":"P4","article-title":"Pulse-therapy with azithromycin in acne rosacea and peri-oral dermatitis: an open study","volume":"52","author":"Ruggero","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB110|cit110","first-page":"99","article-title":"Comparative evaluation by colorimetry and videocapillaroscopy of the efficacy of a cream composed of peptide of lupin and soya isoflavones on erythrocouperose","volume":"24","author":"Sainthillier","year":"2005","journal-title":"Nouvelle Dermatologie"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB111|cit111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2003.10.192","article-title":"Combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"50","author":"Sanchez","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB112|cit112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjo.79.1.42","article-title":"Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea","volume":"79","author":"Seal","year":"1995","journal-title":"British Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub4-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1468-3083.2008.02609.x","article-title":"Rosacea\/acne rosacea: Efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment","volume":"22","author":"Sehgal","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub4-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB115|cit115","first-page":"177","article-title":"A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea","volume":"56","author":"Signore","year":"1995","journal-title":"Cutis"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB116|cit116","first-page":"AB17","article-title":"Evaluation of a topical treatment containing 8% sulfur and 2% resorcinol in the treatment of centrofacial rosacea","volume":"54","author":"Stoudemayer","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub4-BIB117|cit117","first-page":"17","article-title":"Efficacy and safety of subantimicrobial-dose doxycycline for the treatment of rosacea","volume":"52","author":"Thiboutot","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB118|cit118","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1468-3083.2008.02781.x","article-title":"Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea","volume":"23","author":"Togsverd-Bo","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub4-BIB119|cit119","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-4362.1997.00301.x","article-title":"Clarithromycin versus doxycycline in the treatment of rosacea","volume":"36","author":"Torresani","year":"1997","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB120|cit120","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB121|cit121","first-page":"441","article-title":"A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema","volume":"33","author":"Uebelhoer","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB122|cit122","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.1997.tb00469.x","article-title":"Treatment of rosacea with ketoconazole","volume":"8","author":"Uta\u015f","year":"1997","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB123|cit123","first-page":"381","article-title":"Metronidazole cream for the local treatment of rosacea","volume":"150","author":"Veien","year":"1988","journal-title":"Ugeskrift for Laeger"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB124|cit124","first-page":"94","article-title":"Treatment of rosacea fulminans with isotretinoin and topical alclometasone dipropionate","volume":"6","author":"Veraldi","year":"1996","journal-title":"European Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB125|cit125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1358\/dof.2007.032.03.1083308","article-title":"Incyclinide","volume":"32","author":"Viera","year":"2007","journal-title":"Drugs of the Future"},{"key":"10.1002\/14651858.CD003262.pub4-BIB126|cit126","first-page":"E-Abstract 2846","article-title":"Efficacy of cyclosporine a for the treatment of ocular rosacea","volume":"46","author":"Wittpenn","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB127|cit127","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11655-006-0277-1","article-title":"Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone","volume":"12","author":"Yu","year":"2006","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB128|cit128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1346-8138.2004.tb00566.x","article-title":"Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea","volume":"31","author":"Ozt\u00fcrkcan","year":"2004","journal-title":"The Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB129|cit129","first-page":"607","article-title":"Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea","volume":"9","author":"Rosso","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub4-BIB130|cit130","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline - and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"10.1002\/14651858.CD003262.pub4-BIB131|cit131","unstructured":"Kim TG Roh HJ Cho SB Lee JH Lee SJ Oh SH Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: A randomized, prospective, split-face trial British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB132|cit132","first-page":"292","article-title":"Acne rosacea: Effectiveness of 532 nm laser on the cosmetic appearance of the skin","volume":"39","author":"Maxwell","year":"2010","journal-title":"Journal of Otolaryngology - Head & Neck Surgery"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB133|cit133","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-3083.2009.03357.x","article-title":"Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: A randomized controlled trial","volume":"24","author":"Nymann","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB134|cit134","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/lsm.20811","article-title":"Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser","volume":"41","author":"Tierney","year":"2009","journal-title":"Lasers in Surgery and Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB135|cit135","first-page":"647","article-title":"Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea","volume":"9","author":"Tremaine","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB136|cit136","unstructured":"NCT00041977 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00041977"},{"key":"10.1002\/14651858.CD003262.pub4-BIB137|cit137","unstructured":"NCT00348335 Efficacy of Topical Cyclosporin 0.05% for the Treatment of Ocular Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00348335"},{"key":"10.1002\/14651858.CD003262.pub4-BIB138|cit138","unstructured":"NCT00395226 Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00395226"},{"key":"10.1002\/14651858.CD003262.pub4-BIB139|cit139","unstructured":"NCT00483145 Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00483145"},{"key":"10.1002\/14651858.CD003262.pub4-BIB140|cit140","unstructured":"NCT00495313 Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00495313"},{"key":"10.1002\/14651858.CD003262.pub4-BIB141|cit141","unstructured":"NCT00560703 Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00560703"},{"key":"10.1002\/14651858.CD003262.pub4-BIB142|cit142","unstructured":"NCT00617903 A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00617903"},{"key":"10.1002\/14651858.CD003262.pub4-BIB143|cit143","unstructured":"NCT00621218 A Pilot Study to Compare Tretinoin Gel, 0.05% to Tretinoin Gel Vehicle When Dosed Once or Twice Daily in Female Subjects With Classical Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00621218"},{"key":"10.1002\/14651858.CD003262.pub4-BIB144|cit144","unstructured":"NCT00667173 A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00667173"},{"key":"10.1002\/14651858.CD003262.pub4-BIB145|cit145","unstructured":"NCT00697541 A Phase II, Single-Center, Two-Way Crossover Relative Systemic Bioavailability Study of Col-118 Administered Topically as a 0.18 % Facial Gel and Brimonidine Ophthalmic Solution 0.2% Administered to the Eye in Subjects With Moderate to Severe Erythematous Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00697541"},{"key":"10.1002\/14651858.CD003262.pub4-BIB146|cit146","unstructured":"NCT00823901 A Double-Blind, Placebo-Controlled, Pilot Study to Determine the Safety and Efficacy of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel For The Treatment of Rosacea Over 12 Weeks http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00823901"},{"key":"10.1002\/14651858.CD003262.pub4-BIB147|cit147","unstructured":"NCT00882531 Evaluation of the Efficacy of Isotretinoin Versus Placebo in Terms of Response Rate Among Patients Presenting Papular-pustular Rosacea Resistant to Standard Therapy http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00882531"},{"key":"10.1002\/14651858.CD003262.pub4-BIB148|cit148","unstructured":"NCT00892281 A Phase 4, Open-Label, Multicenter, Community-based, 12-Week Trial Assessment of Effectiveness, Safety, and Subject Satisfaction With Oracea\u00ae [Doxycycline, USP] Capsules 40 mg (30 mg Immediate Release & 10 mg Delayed Release Beads) When Used as Monotherapy or as Add-On Therapy to Existing Topical Regimens for the Treatment of Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00892281"},{"key":"10.1002\/14651858.CD003262.pub4-BIB149|cit149","unstructured":"NCT00940992 A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00940992"},{"key":"10.1002\/14651858.CD003262.pub4-BIB150|cit150","unstructured":"NCT00945373 Combination Therapy for the Treatment of Erythematotelangiectatic Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00945373"},{"key":"10.1002\/14651858.CD003262.pub4-BIB151|cit151","unstructured":"NCT00989014 Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Dose-Finding Study Investigating the Pharmacodynamics and Safety of Three Concentrations of CD07805\/47 Topical Gel (0.07%, 0.18%, and 0.50%), Applied in Subjects With Moderate to Severe Erythematotelangiectatic Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00989014"},{"key":"10.1002\/14651858.CD003262.pub4-BIB152|cit152","unstructured":"NCT01016782 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study of 0444 Gel http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01016782"},{"key":"10.1002\/14651858.CD003262.pub4-BIB153|cit153","unstructured":"NCT01025635 Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Study to Investigate the Safety and Efficacy of Azelaic Acid Foam 15% Topically Applied Twice Daily in Subjects With Papulopustular Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01025635"},{"key":"10.1002\/14651858.CD003262.pub4-BIB154|cit154","unstructured":"NCT01045551 An Open Label, Pilot Study to Determine the Efficacy of Apremilast in the Treatment of Rosacea in Patients With Both Erythematotelangiectatic Rosacea and Papulopustular Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01045551"},{"key":"10.1002\/14651858.CD003262.pub4-BIB155|cit155","unstructured":"NCT01125930 Investigation of the Topical Retinoid, Atralin Gel 0.05% for the Treatment of Erythematotelangiectatic Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01125930"},{"key":"10.1002\/14651858.CD003262.pub4-BIB156|cit156","unstructured":"NCT01134991 Pilot, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Moderate to Severe Rosacea Patients http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01134991"},{"key":"10.1002\/14651858.CD003262.pub4-BIB157|cit157","unstructured":"NCT01174030 A 4-week, Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805\/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805\/47 Gel 0.18% Applied Topically Once Daily (QD) or Twice Daily (BID), in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01174030"},{"key":"10.1002\/14651858.CD003262.pub4-BIB158|cit158","unstructured":"NCT01186068 A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01186068"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB159|cit159","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea","volume":"43","author":"Bakar","year":"2004","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB160|cit160","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB161|cit161","first-page":"16","article-title":"Oral therapy for rosacea","volume":"5","author":"Baldwin","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB162|cit162","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaad.2004.04.013","article-title":"Measurement of the severity of rosacea","volume":"51","author":"Bamford","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB163|cit163","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2006.03.023","article-title":"Childhood stye and adult rosacea","volume":"55","author":"Bamford","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB164|cit164","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB165|cit165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/lsm.20621","article-title":"Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser","volume":"40","author":"Bernstein","year":"2008","journal-title":"Lasers in Surgery and Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB166|cit166","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB167|cit167","first-page":"251","article-title":"Rosacea: Where are we now?","volume":"3","author":"Bikowski","year":"2004","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB168|cit168","first-page":"22","article-title":"Demystifying anti-inflammatory dose antibiotics for management of rosacea","volume":"April","author":"Bikowski","year":"2007","journal-title":"Practical Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB169|cit169","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: An update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB170|cit170","first-page":"35","article-title":"Laser and light therapies for acne rosacea","volume":"5","author":"Butterwick","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB171|cit171","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-3083.2006.01991.x","article-title":"An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption","volume":"21","author":"Chu","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB172|cit172","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB173|cit173","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-9740.2005.03740.x","article-title":"Pimecrolimus for treatment of acne rosacea","volume":"4","author":"Crawford","year":"2005","journal-title":"Skinmed"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB174|cit174","first-page":"38","article-title":"Rosacea: A Review","volume":"34","author":"Culp","year":"2009","journal-title":"P & T"},{"issue":"15","key":"10.1002\/14651858.CD003262.pub4-BIB175|cit175","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/sim.1206","article-title":"Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB176|cit176","first-page":"485","article-title":"The role of skin care and maintaining proper barrier function in the management of rosacea","volume":"20","author":"Rosso","year":"2007","journal-title":"Cosmetic Dermatology"},{"issue":"7109","key":"10.1002\/14651858.CD003262.pub4-BIB177|cit177","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB178|cit178","first-page":"120","article-title":"Results of a national rosacea patient survey: Common issues that concern rosacea sufferers","volume":"8","author":"Elewski","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB179|cit179","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: Proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB180|cit180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/17469872.2.5.523","article-title":"Anti-inflammatory dose doxycycline for the treatment of rosacea","volume":"2","author":"Fowler","year":"2007","journal-title":"Expert Review of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB181|cit181","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-4362.2003.01780.x","article-title":"Measuring the severity of rosacea: A review","volume":"42","author":"Gessert","year":"2003","journal-title":"International Journal of Dermatology"},{"issue":"15","key":"10.1002\/14651858.CD003262.pub4-BIB182|cit182","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1517\/14656566.9.15.2699","article-title":"Azelaic acid 15% gel in the treatment of rosacea","volume":"9","author":"Gollnick","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD003262.pub4-BIB183|cit183","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]","author":"Higgins","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB184|cit184","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","article-title":"Rosacea: Classification and treatment","volume":"90","author":"Jansen","year":"1997","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB185|cit185","first-page":"449","article-title":"Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color","volume":"33","author":"Kawana","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB186|cit186","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000077298","article-title":"A personal critique on the state of knowledge of rosacea","volume":"208","author":"Kligman","year":"2004","journal-title":"Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB187|cit187","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB188|cit188","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.2007.08028.x","article-title":"Mite-related bacterial antigens stimulate inflammatory cells in rosacea","volume":"157","author":"Lacey","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB189|cit189","first-page":"145","article-title":"Rosacea: The battle goes on","volume":"31","author":"Landow","year":"2005","journal-title":"Comprehensive Therapy"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD003262.pub4-BIB190|cit190","first-page":"11","article-title":"Photographic review of results from a clinical study comparing benzoyl peroxide 5%\/clindamycin 1% topical gel with vehicle in the treatment of rosacea","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB191|cit191","first-page":"324","article-title":"Rosacea: Relieving a chronic inflammatory facial disorder","volume":"9","author":"McAleer","year":"2006","journal-title":"Geriatrics and Aging"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB192|cit192","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life and rosacea: Pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"Journal of Cosmetic and Laser Therapy"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB193|cit193","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1211\/jpp.59.8.0010","article-title":"Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system","volume":"59","author":"Narayanan","year":"2007","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB194|cit194","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2007.01.048","article-title":"A pilot quality-of-life instrument for acne rosacea","volume":"57","author":"Nicholson","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB195|cit195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB196|cit196","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003262.pub4-BIB197|cit197","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB198|cit198","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: Nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB199|cit199","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub4-BIB200|cit200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB201|cit201","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003226-200401000-00020","article-title":"Oral tetracyclines for ocular rosacea: An evidence-based review of the literature","volume":"23","author":"Stone","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB202|cit202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bjps.2006.11.022","article-title":"Treatment of rhinophyma with the Versajet Hydrosurgery System","volume":"61","author":"Taghizadeh","year":"2008","journal-title":"Journal of Plastic, Reconstructive and Aesthetic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB203|cit203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea. New and emerging therapies","volume":"18","author":"Thiboutot","year":"2000","journal-title":"Dermatologic Clinics"},{"key":"10.1002\/14651858.CD003262.pub4-BIB204|cit204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2288-6-52","article-title":"A system for rating the stability and strength of medical evidence","volume":"6","author":"Treadwell","year":"2006","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD003262.pub4-BIB205|cit205","series-title":"Presented at: Fall Clinical Dermatology Conference. Las Vegas, NV, USA, 7-11 October 2006","article-title":"A multicenter, double-blind, randomized trial to evaluate long-term anti-inflammatory dose doxycycline (40 mg) therapy: Results of the lack of effect on bacterial flora","author":"Walker","year":"2006"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB206|cit206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea. Pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub4-BIB207|cit207","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub4-BIB208|cit208","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard classification of rosacea: Report of the national rosacea society expert committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub4-BIB209|cit209","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub4-BIB210|cit210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"Journal of Dermatological Science"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB211|cit211","article-title":"Interventions for rosacea","author":"Zuuren","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub4-BIB212|cit212","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003262.pub3","article-title":"Interventions for rosacea","author":"Zuuren","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub4-BIB213|cit213","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"Zuuren","year":"2007","journal-title":"Journal of the American Academy of Dermatology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003262.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003262.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T02:49:02Z","timestamp":1712285342000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003262.pub4"}},"subtitle":[],"editor":[{"given":"Esther J","family":"van Zuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":213,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003262.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003262.pub5","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,3,16]]}}}